Aiocd Pharma Limited - Due diligence report

A 360° intelligence report on Aiocd Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress s…

2006-10-16 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
AP Aiocd Pharma Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Aiocd Pharma Limited — 360° Intelligence Report

Generated from MCA filings & public records
80/100
Trust Score
Low Risk

Aiocd Pharma Limited is assessed as Low Risk with a Trust Score of 80/100. Aiocd Pharma Limited is an active public limited indian non-government company incorporated in 2006, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 20 Jul 2026 from the latest processed filings. Aiocd Pharma Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
80/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
58/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 58/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Flagged by authority: NSDL, CDSL.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
DEVESH AMUBHAI PATHAK 01234567 Director 01/04/2018 6 yrs Approved
JAGANNATH SAKHARAM SHINDE 01234567 Director 01/04/2018 6 yrs Approved
RAVINDRA RAIGONDA PATIL 01234567 Director 01/04/2018 6 yrs Approved
Prasad Waman Danave 01234567 Director 01/04/2018 6 yrs Approved
RAVINDRA BAJIRAO PAWAR 01234567 Director 01/04/2018 6 yrs Approved
VIJAY PANDURANG PATIL 01234567 Director 01/04/2018 6 yrs Approved
RAVINDRA RAIGONDA PATIL 01234567 Director 01/04/2018 6 yrs Approved
BASAVRAJ CHANNAPPA MANURE 01234567 Director 01/04/2018 6 yrs Approved
JASHVANT PATEL PRAHLADBHAI 01234567 Director 01/04/2018 6 yrs Approved
VAIJANATH EKNATH JAGUSHTE 01234567 Director 01/04/2018 6 yrs Approved
RINKU RAKESH GADANI 01234567 Director 01/04/2018 6 yrs Approved
RAVEENDRAN BALKRISHNAN 01234567 Director 01/04/2018 6 yrs Approved
  • 12 directors on the board.
  • No disqualified or deactivated DINs.
  • 3 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
-

Promoters hold a minority stake - exact percentages are part of the full report.

Group entityRelationship% held
Pranic Healthcare Distributors Private Limited Subsidiary Company 74.00%

Key managerial personnel: RAVINDRA RAIGONDA PATIL (CFO) · Prasad Waman Danave (Managing Director) · RAVINDRA RAIGONDA PATIL (CFO)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 80
Growth signals & trust indicators
Steady revenue growth: +38% over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 19+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Profit declined two years in a row.
Compliance score is weak (58/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence71/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment68/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view78/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
20 Dec 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
21 Dec 2023
Director ceased
BASAVRAJ CHANNAPPA MANURE
Director ceased
JASHVANT PATEL PRAHLADBHAI
Director ceased
RAVEENDRAN BALKRISHNAN
13 Sep 2023
Director appointed
JASHVANT PATEL PRAHLADBHAI (Director)
Director appointed
VAIJANATH EKNATH JAGUSHTE (Director)
Director appointed
RAVEENDRAN BALKRISHNAN (Director)
02 May 2023
Director appointed
BASAVRAJ CHANNAPPA MANURE (Director)
01 Dec 2022
Director appointed
RINKU RAKESH GADANI (Company Secretary)
28 Sep 2022
Director ceased
RAVINDRA RAIGONDA PATIL
Director ceased
BHAVIIKA BHARATKUMAR JAIN
Director ceased
RAVINDRA BAJIRAO PAWAR
11 Feb 2022
Director appointed
RAVINDRA RAIGONDA PATIL (CFO)
08 Dec 2021
Director appointed
RAVINDRA BAJIRAO PAWAR (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Net worth is positive.
12 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
2 overseas direct investment(s) (ODI) on record - international footprint.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Aljesvin Impex And Contracting Private Limited U45400TN2014PTC097599 Chennai, Tamil Nadu, India
Rudraksh Chemicals Private Limited U24117PN2001PTC016331 Pune, Maharashtra, India
D. C. Steels Limited U27106PB1990PLC010517 Punjab, Punjab, India
Five Star Ispat Private Limited U37100GJ2021PTC127694 Valsad, Gujarat, India
Haryana Steel Supply Company Private Limited U26991WB1995PTC069200 Kolkata, West Bengal, India
Kramer Electronics India Private Limited U31909KA2007FTC043666 Bangalore, Karnataka, India
Bandhu Medical Hall Private Limited U51909WB2016PTC215754 Kolkata, West Bengal, India
Shruti Fashions Private Limited U17119GJ2003PTC042160 Surat, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Aiocd Pharma Limited before audits and certifications: compliance score 58/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Aiocd Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Aiocd Pharma Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 80/100, distress signals and MSME payment-delay disclosures - know whether Aiocd Pharma Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Aiocd Pharma Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Aiocd Pharma Limited an active company?

Aiocd Pharma Limited has MCA status “Active” with a compliance score of 58/100 (Moderate).

Is Aiocd Pharma Limited financially healthy?

Aiocd Pharma Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Aiocd Pharma Limited?

Its overall Trust Score is 80/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Aiocd Pharma Limited?

Promoters hold a minority stake - exact percentages are in the full report. 12 active director(s) are on record.

Does Aiocd Pharma Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Aiocd Pharma Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 58/100 (Moderate).

Is it risky to lend to Aiocd Pharma Limited?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.